ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹6,341 Cr | ₹6,064 Cr | ₹7,230 Cr | ₹6,961 Cr | ₹6,192 Cr |
What is the latest Total Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹6,341 Cr |
Mar2023 | ₹6,064 Cr |
Mar2022 | ₹7,230 Cr |
Mar2021 | ₹6,961 Cr |
Mar2020 | ₹6,192 Cr |
How is Total Liabilities of ALEMBIC PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹6,341 Cr | 4.58 | |
Mar2023 | ₹6,064 Cr | -16.13 | |
Mar2022 | ₹7,230 Cr | 3.86 | |
Mar2021 | ₹6,961 Cr | 12.43 | |
Mar2020 | ₹6,192 Cr | - |
Compare Total Liabilities of peers of ALEMBIC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC PHARMACEUTICALS | ₹19,212.7 Cr | -7.2% | -5.7% | 8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹440,050.0 Cr | 2.7% | 0.9% | 34.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,208.0 Cr | -1.1% | 1.1% | 57.7% | Stock Analytics | |
CIPLA | ₹117,197.0 Cr | 0.6% | -1.7% | 8.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,586.0 Cr | -1.6% | -4.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,496.4 Cr | -0.5% | 2.5% | 36% | Stock Analytics |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC PHARMACEUTICALS | -7.2% |
-5.7% |
8.1% |
SENSEX | -0.7% |
-2.6% |
7.5% |
You may also like the below Video Courses